FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2989530803> ?p ?o ?g. }

• W2989530803 abstract "Abstract Purpose The present study was designed to evaluate the efficacy and safety of combined use of intravenous (IV) TXA administration and topical intraarticular tranexamic acid (TXA) strategy in patients aged over 70 undergoing total hip arthroplasty (THA). Methods One hundred eighty patients were randomized into three groups, including an IV group, a local group, and a combined group. Patients were administrated with 15 mg/kg of IV-TXA in the IV group, 2 g TXA in the topical group, or 15 mg/kg IV-TXA combined with 2 g TXA in the combined group. Total blood loss (TBL), maximum hemoglobin drop, the transfusion rate and the number of allogeneic blood units, and the incidence of deep venous thrombosis (DVT), and pulmonary embolism (PE) were recorded and analyzed. Results TBL was 757.75 ± 188.95 mL in the combined group, which was significantly lower than in the IV group (892.75 ± 218.47) or the topical group (1015.75 ± 288.71) ( p = 0.015, p = 0.001 respectively). The mean values of maximum hemoglobin drop in the combined, IV, and topical groups were 2.67 ± 0.42, 3.28 ± 0.52, and 3.75 ± 0.62 g/dL, respectively, with a significant intergroup difference ( p < 0.001 for all). PE was not detected within 1 month after the surgery. Asymptomatic DVT was reported in 1 patient of the IV group, and in 2 patients from the combined group, while the difference was not statistically significant. Conclusions Compared to intravenous or topical use of TXA, the combined therapy effectively decreased total blood loss and reduced the transfusion rate, simultaneously possessed the same degree of safety in primary THA patients aged over 70." @default.
• W2989530803 created "2019-11-22" @default.
• W2989530803 creator A5053492948 @default.
• W2989530803 date "2019-11-07" @default.
• W2989530803 modified "2023-09-25" @default.
• W2989530803 title "Combined use of intravenous and topical tranexamic acid in patients aged over 70 years old undergoing total hip arthroplasty" @default.
• W2989530803 cites W1487942474 @default.
• W2989530803 cites W1768071396 @default.
• W2989530803 cites W1978375149 @default.
• W2989530803 cites W1984164333 @default.
• W2989530803 cites W1984242781 @default.
• W2989530803 cites W2004253755 @default.
• W2989530803 cites W2019947244 @default.
• W2989530803 cites W2031060308 @default.
• W2989530803 cites W2047967119 @default.
• W2989530803 cites W2055876331 @default.
• W2989530803 cites W2086064501 @default.
• W2989530803 cites W2086090962 @default.
• W2989530803 cites W2105693158 @default.
• W2989530803 cites W2106647634 @default.
• W2989530803 cites W2107339086 @default.
• W2989530803 cites W2110977446 @default.
• W2989530803 cites W2121153627 @default.
• W2989530803 cites W2126479706 @default.
• W2989530803 cites W2140526822 @default.
• W2989530803 cites W2156125313 @default.
• W2989530803 cites W2156515605 @default.
• W2989530803 cites W2158949340 @default.
• W2989530803 cites W2171542172 @default.
• W2989530803 cites W2210337079 @default.
• W2989530803 cites W2255020850 @default.
• W2989530803 cites W2276370991 @default.
• W2989530803 cites W2305316613 @default.
• W2989530803 cites W2308902062 @default.
• W2989530803 cites W2343488708 @default.
• W2989530803 cites W2402544895 @default.
• W2989530803 cites W2418236595 @default.
• W2989530803 cites W2569724767 @default.
• W2989530803 cites W2584297706 @default.
• W2989530803 cites W2741648749 @default.
• W2989530803 cites W2767639473 @default.
• W2989530803 cites W2792069541 @default.
• W2989530803 cites W2809404807 @default.
• W2989530803 cites W2809725684 @default.
• W2989530803 cites W2890011496 @default.
• W2989530803 cites W2899076584 @default.
• W2989530803 cites W317601718 @default.
• W2989530803 cites W4211229530 @default.
• W2989530803 cites W4254038539 @default.
• W2989530803 cites W922491381 @default.
• W2989530803 doi "https://doi.org/10.1186/s13018-019-1384-6" @default.
• W2989530803 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6836663" @default.
• W2989530803 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31699131" @default.
• W2989530803 hasPublicationYear "2019" @default.
• W2989530803 type Work @default.
• W2989530803 sameAs 2989530803 @default.
• W2989530803 citedByCount "10" @default.
• W2989530803 countsByYear W29895308032020 @default.
• W2989530803 countsByYear W29895308032021 @default.
• W2989530803 countsByYear W29895308032022 @default.
• W2989530803 countsByYear W29895308032023 @default.
• W2989530803 crossrefType "journal-article" @default.
• W2989530803 hasAuthorship W2989530803A5053492948 @default.
• W2989530803 hasBestOaLocation W29895308031 @default.
• W2989530803 hasConcept C126322002 @default.
• W2989530803 hasConcept C141071460 @default.
• W2989530803 hasConcept C168563851 @default.
• W2989530803 hasConcept C2776265017 @default.
• W2989530803 hasConcept C2778917026 @default.
• W2989530803 hasConcept C2779637338 @default.
• W2989530803 hasConcept C2780011451 @default.
• W2989530803 hasConcept C2780868729 @default.
• W2989530803 hasConcept C2991743468 @default.
• W2989530803 hasConcept C3019025420 @default.
• W2989530803 hasConcept C42219234 @default.
• W2989530803 hasConcept C68312169 @default.
• W2989530803 hasConcept C71924100 @default.
• W2989530803 hasConceptScore W2989530803C126322002 @default.
• W2989530803 hasConceptScore W2989530803C141071460 @default.
• W2989530803 hasConceptScore W2989530803C168563851 @default.
• W2989530803 hasConceptScore W2989530803C2776265017 @default.
• W2989530803 hasConceptScore W2989530803C2778917026 @default.
• W2989530803 hasConceptScore W2989530803C2779637338 @default.
• W2989530803 hasConceptScore W2989530803C2780011451 @default.
• W2989530803 hasConceptScore W2989530803C2780868729 @default.
• W2989530803 hasConceptScore W2989530803C2991743468 @default.
• W2989530803 hasConceptScore W2989530803C3019025420 @default.
• W2989530803 hasConceptScore W2989530803C42219234 @default.
• W2989530803 hasConceptScore W2989530803C68312169 @default.
• W2989530803 hasConceptScore W2989530803C71924100 @default.
• W2989530803 hasIssue "1" @default.
• W2989530803 hasLocation W29895308031 @default.
• W2989530803 hasLocation W29895308032 @default.
• W2989530803 hasLocation W29895308033 @default.
• W2989530803 hasLocation W29895308034 @default.
• W2989530803 hasLocation W29895308035 @default.
• W2989530803 hasOpenAccess W2989530803 @default.
• W2989530803 hasPrimaryLocation W29895308031 @default.
• W2989530803 hasRelatedWork W1987650180 @default.
• W2989530803 hasRelatedWork W2058827628 @default.

• next